+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global AI-based Clinical Trials Solution Provider Market Size, Share & Trends Analysis Report by Therapeutic Application (Oncology, Cardiovascular Diseases, Metabolic Diseases), by Clinical Trial Phase, by End User, by Region, and Segment Forecasts, 2021-2028

  • ID: 5390518
  • Report
  • June 2021
  • Region: Global
  • 118 pages
  • Grand View Research

FEATURED COMPANIES

  • AiCure, LLC
  • CONSILX
  • Exscientia
  • IBM Watson
  • Median Technologies
  • Saama Technologies
The global AI-based clinical trials solution provider market size is expected to reach USD 5.2 billion by 2028 and is expected to expand at a CAGR of 21.7% over the forecast period. Rising adoption of AI-based platforms and technologies by pharmaceutical companies and academia, along with increasing adoption of artificial intelligence (AI) are among the factors driving the market growth. In addition, increasing public and private sector offerings for boosting the research and development in various therapeutic areas, coupled with diverse applications provided by AI in the field of clinical trials is further supporting the growth.



Based on phase, the phase-II segment dominated the market with a share of 48.5% in 2020. This high share is attributable to a higher number of active interventional studies in the second phase. Furthermore, the second phase is crucial for analyzing the immediate outcome of the overall desired outcome from the completion of clinical trials. In addition, since improvements in the further phases of the trial and determination of measures with regards to AI-based tools can be effectively carried out in this phase, the segment comprises of higher revenue share.

In 2020, based on therapeutic applications, the oncology segment accounted for the highest revenue share in the market owing to a growing number of interventional studies in the oncology field and the rising prevalence of cancer. Furthermore, the rising number of market players developing and adopting oncology-based AI tools for clinical trials is further anticipated to propel segment growth.

Based on end-user, the pharmaceutical companies segment accounted for the highest revenue share in the market in 2020 owing to the increasing adoption of AI-based technologies for drug development and interventional studies by major pharmaceutical players. In addition, growing strategic developments in the form of partnerships, acquisitions, collaborations, and mergers are further bolstering the market growth.

North America dominated the market and accounted for the largest revenue share of 43.6% in 2020 owing to various factors including a rising number of start-ups and AI in drug development-based companies in the region, growing awareness and adoption of AI-based technologies, an increasing number of interventional studies. In addition, supportive government initiatives and growing strategic initiatives by major players are driving the demand for AI-based clinical trial solutions in the region.

In addition, the COVID-19 pandemic has also led to a surge in the utilization of AI-based technologies. Increasing adoption of technologically advanced solutions for drug development and utilization of such solutions for analyzing the recruited patient’s data are some of the prominent factors contributing to the upsurge in adoption during the pandemic. Furthermore, the pandemic was also responsible for many clinical trials being put on hold and hence major companies shifted their focus on utilizing AI-based solutions, thereby boosting decentralized interventional studies. Moreover, a large amount of patient data analyzed and consolidated effectively through these solutions has further supported the market growth. For instance, according to a 2021 article published in Healthcare IT News, there is an increase in the adoption of AI-based clinical trial solutions for oncology during COVID-19. Therefore, such instances signify affirmative growth of the market, even during the pandemic.

AI-based Clinical Trials Solution Provider Market Report Highlights

  • The market is anticipated to witness significant growth by 2028 owing to various applications provided by AI in the field of clinical trials and the growing adoption of such platforms by pharmaceutical companies
  • The phase-II trials segment dominated the market in 2020, owing to the increasing number of interventional studies active in this phase
  • The oncology segment dominated the market in 2020, owing to the rising prevalence of cancer and a growing number of interventional studies in the oncology field
  • The pharmaceutical companies segment accounted for the highest revenue share in 2020 owing to the increasing adoption of artificial intelligence technologies for drug development by major pharmaceutical players
  • North America dominated the market and accounted for the largest revenue share of 43.6% in 2020, owing to various factors including an increasing number of clinical trials in the region, growing adoption of artificial intelligence platforms and tools, rising number of start-ups and companies based on artificial intelligence in drug development and growing awareness regarding AI-based tools and technologies

This report will be delivered within 1-3 business days.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AiCure, LLC
  • CONSILX
  • Exscientia
  • IBM Watson
  • Median Technologies
  • Saama Technologies
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 Internal database
1.3.2 Primary Research
1.4 Research Scope and Assumptions
1.5 List of Data Sources

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook

Chapter 3 Global AI-based Clinical Trial Solution Providers Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Global AI-based Clinical Trial Solution Providers Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.4.3 Major Deals & Strategic Alliances Analysis
3.5 COVID-19 Impact on the market

Chapter 4 AI-based Clinical Trial Solution Providers Market: Clinical Trial Phase Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Market: Clinical Trial Phase Market Share Analysis, 2020 and 2028
4.3 Phase-I
4.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
4.4 Phase-II
4.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
4.5 Phase-III
4.5.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 5 AI-based Clinical Trial Solution Providers Market: Therapeutic Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Market: Therapeutic Application Market Share Analysis, 2020 and 2028
5.3 Oncology
5.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
5.4 Cardiovascular Diseases
5.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
5.5 Neurological Diseases or Conditions
5.5.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
5.6 Metabolic Diseases
5.6.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
5.7 Infectious Diseases
5.7.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
5.8 Others
5.8.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 6 AI-based Clinical Trial Solution Providers Market: End-user Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Market: End-user Market Share Analysis, 2020 and 2028
6.3 Pharmaceutical Companies
6.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.4 Academia
6.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.5 Others
6.5.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 7 AI-based Clinical Trial Solution Providers Market: Regional Estimates & Trend Analysis, By Clinical Trial Phase, Therapeutic Application & End Users
7.1 Global AI-based Clinical Trial Solution Providers Market: Regional Movement Analysis
7.2 North America
7.2.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3 Europe
7.3.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3.2 U.K.
7.3.2.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3.3 Germany
7.3.3.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3.4 Spain
7.3.4.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3.5 France
7.3.5.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3.6 Italy
7.3.6.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.3.7 Russia
7.3.7.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.4.2 China
7.4.2.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.4.3 Japan
7.4.3.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.4.4 India
7.4.4.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.4.5 South Korea
7.4.5.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.4.6 Australia
7.4.6.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.5 Latin America
7.5.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.5.3 Mexico
7.5.3.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.5.4 Argentina
7.5.4.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.6 MEA
7.6.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)
7.6.4 UAE
7.6.4.1 Market estimates and forecasts by clinical trial phase, therapeutic application, and end users 2016 - 2028 (USD Million)

Chapter 8 Company Profiles
8.1 Unlearn.AI, Inc.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Saama Technologies
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 Antidote Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Exscientia
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Google Inc. (Verily)
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 IBM Watson
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 GNS Healthcare
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 BioSymetrics
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiatives
8.9 Euretos
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Koneksa Health
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
8.11 Trials.Ai
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.11.4 Strategic Initiatives
8.12 Ardigen
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Product Benchmarking
8.12.4 Strategic Initiatives
8.13 Pharmaseal
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.13.4 Strategic Initiatives
8.14 Halo Health Systems
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.14.4 Strategic Initiatives
8.15 DEEP LENS AI
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.15.4 Strategic Initiatives
8.16 CONSILX
8.16.1 Company Overview
8.16.2 Financial Performance
8.16.3 Product Benchmarking
8.16.4 Strategic Initiatives
8.17 AiCure, LLC
8.17.1 Company Overview
8.17.2 Financial Performance
8.17.3 Product Benchmarking
8.17.4 Strategic Initiatives
8.18 BioAge Labs, Inc.
8.18.1 Company Overview
8.18.2 Financial Performance
8.18.3 Product Benchmarking
8.18.4 Strategic Initiatives
8.19 Symphony AI
8.19.1 Company Overview
8.19.2 Financial Performance
8.19.3 Product Benchmarking
8.19.4 Strategic Initiatives
8.20 Median Technologies
8.20.1 Company Overview
8.20.2 Financial Performance
8.20.3 Product Benchmarking
8.20.4 Strategic Initiatives
8.21 Intelligencia
8.21.1 Company Overview
8.21.2 Financial Performance
8.21.3 Product Benchmarking
8.21.4 Strategic Initiatives
8.22 Mendel.ai
8.22.1 Company Overview
8.22.2 Financial Performance
8.22.3 Product Benchmarking
8.22.4 Strategic Initiatives
8.23 Innoplexus
8.23.1 Company Overview
8.23.2 Financial Performance
8.23.3 Product Benchmarking
8.23.4 Strategic Initiatives
8.24 Deep 6 AI
8.24.1 Company Overview
8.24.2 Financial Performance
8.24.3 Product Benchmarking
8.24.4 Strategic Initiatives
8.25 Phesi
8.25.1 Company Overview
8.25.2 Financial Performance
8.25.3 Product Benchmarking
8.25.4 Strategic Initiatives

List of Tables
Table 1 North America AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 2 North America AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 3 North America AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 4 U.S. AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 5 U.S. AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 6 U.S. AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 7 Canada. AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 8 Canada AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 9 Canada AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 10 Europe AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 11 Europe AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 12 Europe AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 13 U.K. AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 14 U.K. AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 15 U.K. AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 16 Germany AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 17 Germany AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 18 Germany AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 19 Spain AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 20 Spain AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 21 Spain AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 22 France AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 23 France AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 24 France AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 25 Italy AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 26 Italy AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 27 Italy AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 28 Russia AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 29 Russia AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 30 Russia AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 31 Asia Pacific AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 32 Asia Pacific AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 33 Asia Pacific AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 34 China. AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 35 China AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 36 China AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 37 Japan AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 38 Japan AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 39 Japan AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 40 India AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 41 India AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 42 India AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 43 Australia AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 44 Australia AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 45 Australia AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 46 South Korea AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 47 South Korea AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 48 South Korea AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 49 Latin America AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 50 Latin America AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 51 Latin America AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 52 Brazil AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 53 Brazil AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 54 Brazil AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 55 Mexico AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 56 Mexico AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 57 Mexico AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 58 Argentina AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 59 Argentina AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 60 Argentina AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 61 Middle East & Africa AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 62 Middle East & Africa AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 63 Middle East & Africa AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 64 South Africa AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 65 South Africa AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 66 South Africa AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 67 Saudi Arabia AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 68 Saudi Arabia AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 69 Saudi Arabia AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)
Table 70 UAE AI-based Clinical trial solution providers market estimates and forecasts, by clinical trial phase, 2016 - 2028 (USD Million)
Table 71 UAE AI-based Clinical trial solution providers market estimates and forecasts, by therapeutic application, 2016 - 2028 (USD Million)
Table 72 UAE AI-based Clinical trial solution providers market estimates and forecasts, by end user, 2016 - 2028 (USD Million)

List of Figures
Fig. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 AI-based Clinical trial solution providers market snapshot, 2020, (USD Million)
FIG. 6 AI-based Clinical trial solution providers market trends & outlook
FIG. 7 Penetration & growth prospect mapping
FIG. 8 Market driver analysis (Current & future impact)
FIG. 9 Market restraint analysis (Current & future impact)
FIG. 10 AI-based Clinical trial solution providers market, clinical trial phase outlook key takeaways (USD Million)
FIG. 11 AI-based Clinical trial solution providers market: clinical trial phase movement analysis (USD Million), 2020 & 2028
FIG. 12 Phase-I market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 13 Phase-II market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 14 Phase-III market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 15 AI-based Clinical trial solution providers market, therapeutic application outlook key takeaways (USD Million)
FIG. 16 AI-based Clinical trial solution providers market: therapeutic application movement analysis (USD Million), 2020 & 2028
FIG. 17 Oncology market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 18 Cardiovascular Diseases market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 19 Neurological Diseases or Conditions market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 20 Metabolic Diseases market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 21 Infectious Diseases market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 22 Others market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 23 AI-based Clinical trial solution providers market, end-user outlook key takeaways (USD Million)
FIG. 24 AI-based Clinical trial solution providers market: end-user movement analysis (USD Million), 2020 & 2028
FIG. 25 Pharmaceutical companies market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 26 Academia market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 27 Others market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 28 AI-based Clinical trial solution providers market, regional outlook key takeaways (USD Million)
FIG. 29 AI-based Clinical trial solution providers market: regional movement analysis (USD Million), 2020 & 2028
FIG. 30 North America AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 31 U.S. AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 32 Canada AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 33 Europe AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 34 U.K. AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 35 Germany AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 36 Spain AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 37 France AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 38 Italy AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 39 Russia AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 40 Asia Pacific AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 41 China AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 42 Japan AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 43 India AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 44 South Korea AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 45 Australia AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 46 Latin America AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 47 Brazil AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 48 Mexico AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 49 Argentina AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 50 MEA AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 51 South Africa AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 52 Saudi Arabia AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 53 UAE AI-based Clinical trial solution providers market estimates and forecasts, 2016 - 2028 (USD Million)
Note: Product cover images may vary from those shown
  • Unlearn.AI, Inc.
  • Saama Technologies
  • Antidote Technologies, Inc.
  • Exscientia
  • Google Inc. (Verily)
  • IBM Watson
  • GNS Healthcare
  • BioSymetrics
  • Euretos
  • Koneksa Health
  • Trials.Ai
  • Ardigen
  • Pharmaseal
  • Halo Health Systems
  • DEEP LENS AI
  • CONSILX
  • AiCure, LLC
  • BioAge Labs, Inc.
  • Symphony AI
  • Median Technologies
  • Intelligencia
  • Mendel.ai
  • Innoplexus
  • Deep 6 AI
  • Phesi
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll